Air pollution linked to more severe COVID-19
Scientists from the University of California San Diego found that some common air pollutants, such as ground-level ozone, are associated with more severe outcomes...
Vaccination could reduce long COVID symptoms, shows study
Graham was a healthy 34-year-old until he developed COVID in July 2020.
Along with his wife and children, he had a fever, a cough, breathlessness,...
Long COVID may harm vaccinated people, too
Scientists from Washington University in St. Louis found that even vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect...
Long COVID could affect people 15 months after initial infection
Scientists from Northwestern Medicine found many non-hospitalized COVID-19 "long-haulers" continued to experience symptoms such as brain fog, numbness and tingling, headache, dizziness, blurred vision,...
For these people, mild COVID-19 can still lead to dangerous health issues
Scientists recently found adults over age 50 who experience mild or moderate COVID-19 are at greater risk of worsening mobility and physical function.
The findings...
How to keep yourself safe from COVID-19
As COVID-19 cases continue to fluctuate around the country, it has become clear that the coronavirus that causes the disease is unlikely to disappear.
But...
COVID-19 mixed with flu can increase risks of death, severe COVID-19
Scientists from the University of Edinburgh found that adults in hospitals who have COVID-19 and the flu at the same time are at much...
Scientists find lung problems in people with long COVID
Scientists from the University of Oxford found that a special type of MRI showed lung abnormalities in patients who had previously had COVID-19, even...
COVID-19 may damage right side of your heart
Scientists from the University of Glasgow found that the COVID-19 virus is linked to impaired function of the right side of the heart.
These findings...
All Omicron subvariants can reduce vaccine protection
Scientists from Columbia University found only one currently authorized antibody treatment retains its activity against all Omicron subvariants.
They also found that the effectiveness of...